Form 4: Chemours Executive Sells 7,500 Shares in Open Market Transaction

A Chemours executive, Alvenia Scarborough, sold 7,500 shares of common stock at a weighted average price of $20.6361 per share.

Summary

• Alvenia Scarborough, a Senior Vice President at Chemours, sold 7,500 shares of the company's common stock on November 7, 2024.
• The shares were sold at a weighted average price of $20.6361 per share, with individual transaction prices ranging from $20.60 to $20.68.
• Following the transaction, Ms. Scarborough directly owns 16,645.1662 shares, which includes directly owned shares, restricted stock units, and dividend equivalent units.
• The reported holdings also reflect a correction, reducing previously reported shares by 2,940 due to an error in prior filings.

Sentiment

Score: 5

Explanation: The document is a neutral report of a routine stock sale by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives of publicly traded companies. It does not indicate any specific trend in the chemical industry.

Comparison to Industry Standards

• Executive stock sales are a normal part of compensation and portfolio management for executives in publicly traded companies, including those in the chemical industry like Dow and BASF.
• The sale of 7,500 shares is not unusual for an executive at this level and is within the typical range of insider transactions.
• The price range of $20.60 to $20.68 is consistent with the market price of Chemours stock at the time of the transaction.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial position.

Key Dates

Keywords

Chemours, stock sale, insider trading, executive, common stock, Alvenia Scarborough, SEC Form 4